Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caris Life Sciences (CAI) Revenue (2024 - 2025)

Caris Life Sciences (CAI) has 2 years of Revenue data on record, last reported at $292.9 million in Q4 2025.

  • For Q4 2025, Revenue rose 125.44% year-over-year to $292.9 million; the TTM value through Dec 2025 reached $590.7 million, changed N/A, while the annual FY2025 figure was $812.0 million, 96.97% up from the prior year.
  • Revenue reached $292.9 million in Q4 2025 per CAI's latest filing, up from -$13.5 million in the prior quarter.
  • Across five years, Revenue topped out at $292.9 million in Q4 2025 and bottomed at -$13.7 million in Q2 2024.